Unleashing the Power of Cellular Medicine

The Mygotic Process™ Is Transforming the Creation of Autologous Totipotent Cells from Somatic Cells While Erasing All Epigenetics Without Altering DNA.

MygoGenesis™ is unleashing the power of cellular medicine.  The Mygotic™ proprietary process turns somatic cells to totipotent cells and then to any cell or tissue with none of the challenges of alternative methods. We are advancing the science to revolutionize therapeutics, cellular medicines, food and water testing, and regenerative medicine. Learn more about our pipeline of companies.

Sustainable Amebocyte Production for LAL Testing to Detect Bacterial Contamination.

HematoGenesis™

Type O Negative blood production advancing medical science and healthcare delivery.

The banking of autologous cells – cells derived from one’s own body – for availability for future medical needs.

Partnerships and licensing for the Mygotic™ Platform to produce valuable cells for medical research and other applications.